Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Medicaid spending on GLP-1s has grown exponentially over the past five years, reflecting both an increase in GLP-1 usage and expanded coverage in many states
00:30:05 Jennifer Trujillo So more to come on that
When GLP-1 binds to its receptor, it amplifies the insulin signaling pathway, causing increased phosphorylation of insulin receptor substrates and activating the PI3K/Akt pathway, which ultimately results in enhanced glucose uptake, utilization within the liver, and reduced production of glucose (gluconeogenesis)
My aim is simple: to walk you through why constipation happens on GLP-1s, share foundational strategies that actually work, and point you toward practical resourcesrecipes, meal plans, and food listsdesigned for real life (and sensitive stomachs)
The American Association of Clinical Endocrinologists (AACE) does not have a formal position on compounded GH secretagogues, but the organization's general guidance on GH therapy emphasizes that IGF-1 monitoring is the primary safety and efficacy marker regardless of the GH-stimulating modality used